Arava, the first drug to be approved for the treatment of active rheumatoid arthritis in 13 years, received an approval for slowing progression of the disease, as well. Other treatments are also thought to retard the disease but aren't labeled as such.
According to Hoechst-Marion Roussel, the average wholesale price for the drug will be $8 per day, and, although no DTC advertising has been implemented or is planned, consumer response news reports of the drug's availability have been "overwhelming." Shipping and distribution began in mid-September for mid-to-late October availability in retail pharmacies.
COPYRIGHT 1998 Lebhar-Friedman, Inc.
COPYRIGHT 2000 Gale Group
Home
A
8-Hour Bayer
